Clinical efficacy of dienogest against endometriomas with a maximum diameter of ≥4 cm

Clinical efficacy of dienogest against endometriomas with a maximum diameter of ≥4 cm

Objective This prospective observational study aims to demonstrate the clinical efficacy of dienogest in treating endometriomas with a maximum diameter of ≥4 cm.Methods Patients (n = 81) with endometriomas (diameter of ≥4 cm) were enrolled and administered orally with dienogest (2 mg daily) and foll...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yan Huang, Deyu Zhang, Lei Zhang, Yingfang Zhou, Chao Peng
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Annals of Medicine
Subjects:	Dienogest pharmacotherapy endometriosis endometriomas adverse effects
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2402942
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of dienogest treatment on endometrioma-related clinical symptoms and endometrioma size: retrospective cohort study
by: Ufuk Atlihan, et al.
Published: (2025-05-01)

The conservative management of ovarian endometrioma using cyst aspiration followed by dienogest medication: a pilot study
by: Ha Eun Jung, et al.
Published: (2025-06-01)

Efficacy of dienogest (Zafrilla) in the treatment of endometriosis: A literature review using meta-analysis tools
by: Nikolai N. Rukhliada, et al.
Published: (2025-01-01)

Hemostatic effects of kyukikyogaito in dienogest treatment
by: H. Takagi, et al.
Published: (2020-08-01)

Non-inferiority study to compare the efficacy of relugolix with dienogest for endometriosis-associated pain and usefulness of administering relugolix prior to dienogest (READY study): study protocol for a multicenter randomized controlled study
by: Fuminori Taniguchi, et al.
Published: (2025-02-01)

Statins: Is it New Weaponry against Endometriosis?
by: Sharmin Salam, et al.
Published: (2025-04-01)

Mapping deep endometriosis in patients with ovarian endometriomas according to the #Enzian classification: a single-center retrospective analysis
by: Vimee Bindra, et al.
Published: (2025-07-01)

A Rare Case of a Large Composite Endometrioma–Mature Cystic Teratoma: The Importance of Surgical Treatment and Pathologic Diagnosis
by: Jun Song, et al.
Published: (2024-11-01)

Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines
by: Ilaria Piacenti, et al.
Published: (2025-08-01)

A Narrative Review Regarding Implication of Ovarian Endometriomas in Infertility
by: Constantin-Cristian Văduva, et al.
Published: (2025-01-01)

Clinical features of patients with previous spontaneous rupture of ovarian endometrioma operated electively: a case-control study
by: Zhiyue Gu, et al.
Published: (2023-10-01)

Effect of embryo cryopreservation before surgery on clinical outcomes in IVF patients with endometrioma
by: Nozomi Takahashi, et al.
Published: (2025-01-01)

Ascitis secundaria a endometriosis
by: René Rafael Bonachea Peña, et al.
Published: (2022-04-01)

Endometrioma: A Comprehensive Review of Its Varied Presentations, Complications, and Impact on Patient Management
by: Soumyadeep Ghosh, et al.

Skar endometriozis: 3 olgu sunumu ve literatürün gözden geçirilmesi
by: Onur Bora Aslan, et al.
Published: (2013-01-01)

Early Embryo Development in Women with Endometriosis: A Retrospective Study
by: Mukhri Hamdan, et al.
Published: (2025-06-01)

Eficácia, efetividade e segurança do dienogeste para o tratamento da endometriose: uma revisão sistemática
by: Gabriel Rodrigues Martins de Freitas, et al.
Published: (2025-05-01)

Long-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis
by: Chi-Hau Chen, et al.
Published: (2025-03-01)

Comparison of Surgical Interventions for Endometrioma: A Systematic Review of Their Efficacy in Addressing Infertility
by: Alexandra Ioannidou, et al.
Published: (2024-12-01)

Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review
by: Shiyu Zhang, et al.
Published: (2025-06-01)

Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women
by: Sofie Orlov, et al.
Published: (2022-05-01)

Exploring the Association Between the Doppler Findings of Endometriomal Wall Vascularization and Volume of the Endometrioma
by: Berna Seçkin, et al.
Published: (2013-04-01)

Why should we check the tubes in IVF patients with ovarian endometriosis before embryo transfer? a retrospective study
by: Caglar Yazicioglu, et al.
Published: (2025-04-01)

The impact of surgical intervention on time to conception and obstetric outcomes in women with endometriomas: a retrospective cohort study
by: Halis Doğukan Özkan, et al.
Published: (2025-08-01)

Comparative Study of 0.5 mg Dienogest Tablets (1 mg/Day) and Continuous Low-Dose Estrogen/Progestin for Dysmenorrhea: A Retrospective Analysis—Influence of Bleeding-Related Factors Such as Endometrial Polyps, Uterine Fibroids, and Adenomyosis
by: Haruko Yokosuka
Published: (2025-03-01)

Evaluation of endometrioma size effect on IVF outcomes in young infertile women candidates for IVF cycle
by: Mojgan Javedani Masroor, et al.
Published: (2025-06-01)

To operate or not to operate? The impact of surgical treatment on quality of life in women with ovarian endometriosis
by: Emanuela Spagnolo, et al.
Published: (2025-06-01)

Correlation of ferritin and glutathione peroxidase 4 (GPX4) level as a marker of ferroptosis process in endometrioma
by: Rina Nulianti, et al.
Published: (2025-02-01)

Postoperative management of patients with endometriosis
by: Ju. E. Dobrokhotova, et al.
Published: (2020-07-01)

Can the MMP-9/NGAL ratio be a diagnostic biomarker for the diagnosis of endometrioma in infertile patients?
by: Batuhan Turgay, et al.
Published: (2025-07-01)

Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol
by: Pedro-Antonio Regidor, et al.
Published: (2025-12-01)

Peculiarities of cytokine type of regulation of immune answer in women with ovarian endometriomas
by: O. S. Shapoval, et al.
Published: (2017-10-01)

Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
by: Haruka Nishida, et al.
Published: (2025-03-01)

Effects of GnRH Agonist and Dienogest in Combination on HE4 and CA125 Levels in Patients with Adenomyosis and Adenomyoma: A Prospective Cohort Study
by: DongGe Wang, et al.
Published: (2023-07-01)

Excision of benign multicystic peritoneal mesothelioma and deep infiltrating endometriosis with bowel involvement – A case report
by: Zahra Azeem, et al.
Published: (2024-12-01)

Importance of complement system components in ovarian endometriomas. A comparative cohort study
by: Anna V. Chizhova, et al.
Published: (2024-12-01)

A comparative analysis of progestin-primed ovarian stimulation versus GnRH antagonists protocols pertaining to stimulation parameters and embryological outcomes in patients with endometrioma
by: Fazilet Kubra Boynukalin, et al.
Published: (2025-07-01)

Rare and acute complications of endometriosis in pregnant women
by: E. N. Vaulina, et al.
Published: (2021-03-01)

Overexpression of miR-21-5p as a potential pathogenesis marker for ovarian endometriosis
by: Mohamed Mahmoud, et al.
Published: (2025-01-01)

Is There a Role of 25-Hydroxy Vitamin D in the Pathogenesis of Mild and Moderate-to-Severe Endometriosis?
by: Nevin Tuten, et al.
Published: (2021-08-01)